Targeted Hyperactivation of Oncogenic Signaling as Therapeutic Strategy in B-Cell Malignancies
Markus Müschen, MD, PhD
Arthur H. and Isabel Bunker Professor of Medicine, Hematology and Immunobiology
Chief, Division of Basic Science, Yale Cancer Center
Director, Center of Molecular and Cellular Oncology
Yale University
New Haven, CT
Host: Dr. Andrew Intlekofer
Tea Time: 1:15 PM
